Image source: © 2025 Krish Capital Pty.Ltd

Highlights

  • MetaVia closes at 1.50 USD, up 115.55% on September 15, with ~90M shares changing hands.
  • Intraday high reached 1.68 USD, low at 0.68 USD, triggering a Limit Up–Limit Down (LULD) halt.
  • Public float turnover exceeded 10×, illustrating extreme relative volume in a thinly traded equity.

MetaVia Inc. (NASDAQ:MTVA), a clinical-stage biotech listed in the USA, experienced a dramatic session on Monday, September 15, 2025 (U.S. ET), closing at 1.50 USD, up +115.55% from the prior day’s 0.70 USD. Intraday activity ranged from 0.68 USD to 1.68 USD, with roughly 90 million shares changing hands. The stock’s unusual momentum led to a LULD trading pause at 3:06 p.m. ET, marking one of the most intense single-day moves for a micro-cap biotech.

At the close, MetaVia’s public float was approximately 8.68 million shares, with insiders holding around 64%. The volume effectively cycled the available float more than ten times, creating a mechanical imbalance that fueled rapid price escalation. Relative volume was nearly 830× the typical daily average, indicating extraordinary order-flow pressure. No company press release coincided with the spike, suggesting the movement was primarily structure- and flow-driven rather than news-based.

Market observers note that a recent analyst update on September 4, 2025, with a Buy rating and $12 target, alongside continued interest in MetaVia’s obesity and metabolic disease programs, provided a narrative anchor for momentum participants. The company’s DA-1726 obesity program, featuring a dual GLP-1/glucagon receptor agonist, saw the 48 mg multiple-ascending-dose cohort extended to eight weeks, maintaining attention on potential Q4’25 readouts.

Additional factors included tactical balance-sheet signals, such as $17.6 million in cash at Q2’25 end and insider share purchases, which helped reduce near-term overhang concerns. Combined with visibility on Nasdaq’s Most Active list, the surge drew heightened attention from momentum algorithms and retail platforms, amplifying the session’s volume and volatility.